Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-014834
Filing Date
2023-05-01
Accepted
2023-05-01 06:30:21
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 319893
2 ex31-1.htm EX-31.1 6837
3 ex31-2.htm EX-31.2 6720
4 ex32-1.htm EX-32.1 9302
  Complete submission text file 0001493152-23-014834.txt   604448

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ghsi-20221231.xsd EX-101.SCH 3245
6 XBRL LABEL FILE ghsi-20221231_lab.xml EX-101.LAB 36244
7 XBRL PRESENTATION FILE ghsi-20221231_pre.xml EX-101.PRE 23758
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 7777
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

EIN.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38861 | Film No.: 23869821
SIC: 2834 Pharmaceutical Preparations